Effect modification by vitamin C on the relation between gastric cancer and Helicobacter pylori

European Journal of Epidemiology

Volumn 20, Issue 1, 2005, Pages 67-71

  Kim, Dae Sung ^a   Lee, Moo Song ^b   Kim, Young Sik ^b   Kim, Dong Hyun ^c   Bae, Jong Myon ^d   Shin, Myung Hee ^e   Ahn, Yoon Ok ^a,f  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Hallym University College of Medicine   (South Korea)

^d Jeju National University School of Medicine   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f Seoul National University   (South Korea)

Author keywords

Ascorbic acid; Case control studies; Effect modifiers; Helicobacter pylori; Stomach neoplasm

Indexed keywords

ASCORBIC ACID; IMMUNOGLOBULIN G;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER EPIDEMIOLOGY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DIET SUPPLEMENTATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOD INTAKE; FREQUENCY ANALYSIS; GASTRITIS; HELICOBACTER PYLORI; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; SEROTYPING; SMOKING; STOMACH CANCER; STOMACH ULCER;

ADULT; ASCORBIC ACID; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; KOREA; MALE; MIDDLE AGED; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; STOMACH NEOPLASMS;

EID: 13444291274     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10654-004-1027-y     Document Type: Article

References (33)

1. International Agency for Research on Cancer, World Health Organization. Infection with Helicobacter pylori. In: Schistosomes, liver flukes and Helicobacter pylori. Lyon: IARC, 1994.
2. Holocombe C. Helicobacter pylori: The African enigma. Gut 1992; 33: 429-431.
3. Parkin DM, Muir CS, Whelan SL, et al. Cancer incidence in five continents, Vol VI. Lyon: IARC Scientific Publications no 120, 1992.
4. Palli D, Decarli A, Cipriani F, et al. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev 1993 Jan-Feb; 2(Suppl 1): 37-40.
5. Sierra R, Munoz N, Pena AS, et al. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: Comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomarkers Prev 1992 Sep-Oct; 1(Suppl 6): 449-454.
6. Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993 Jul; 4(Suppl 4): 297-305.
7. Fukao A, Komatsu S, Tsubono Y, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: A cross-sectional study. Cancer Causes Control 1993; 4(Suppl 4): 307-312.
8. Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66(Suppl 12): 2569-2574.
9. Lin HZ, Zhang YC, Zhang WF, et al. Campylobacter pyloridis (Cp) infection of gastric mucosa in the high and low risk areas of gastric cancer in Liaoning province. Chin J Oncol 1989; 11: 365-367.
10. Forman D, Sitas F, Newell DG, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608-611.
11. The EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-1362.
12. Perez-Perez GI, Bhat N, Gaensbauer J, et al. Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infection. Int J Cancer 1997; 72: 453-456.
13. Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
14. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-2115.
15. Kuipers EJ, Perez-Perez GI, Meuwissen SGM, et al. Helicobacter pylori and atrophic gastritis; importance of the cagA status. J Natl Cancer Inst 1995; 87: 1777-1780.
16. Rokkas T, Papatheodorou G, Karameris A, et al. Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication. Dig Dis Sci 1995; 40: 615-621.
17. Ruiz B, Rood JC, Fontham ET, et al. Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment. Am J Gastroenterol 1994; 89: 533-539.
18. Banerjee S, Hawksby C, Miller S, et al. Effect of Helicobacter pylori and its eradication on gastric juice ascorbic acid. Gut 1994; 35: 317-322.
19. Sobala GM, Schorah CJ, Shires S, et al. Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut 1993; 34: 1038-1041.
20. Schlesselman JJ. Case-control studies. New York: Oxford Univ. Press, 1982.
21. The Korean Nutrition Society. Food values of portions commonly used. Seoul, Korea: The Korean Nutrition Information Center, 1998.
22. Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer 2002; 5(Suppl 3): 177-182.
23. Youn HS, Baik SC, Cho YK, et al. Comparison of Helicobacter pylori infection between Fukuoka, Japan and Chinju, Korea. Helicobacter 1998 Mar; 3(Suppl 1): 9-14.
24. Lunet N, Barros H. Helicobacter pylori infection and gastric cancer: Facing the enigmas. Int J Cancer 2003 Oct 10; 106(Suppl 6): 953-960.
25. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, et al. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev 1998 Dec; 7(Suppl 6): 449-454.
26. Sjunnesson H, Sturegard E, Willen R, et al. High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of Helicobacter pylori in the guinea pig. Comp Med 2001 Oct; 51(Suppl 5): 418-423.
27. Zhang HM, Wakisaka N, Maeda O, et al. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: Helicobacter pylori. Cancer 1997 Nov 15; 80(Suppl 10): 1897-1903.
28. Zhang ZW, Abdullahi M, Farthing MJ. Effect of physiological concentrations of vitamin C on gastric cancer cells and Helicobacter pylori Gut 2002 Feb; 50(Suppl 2): 165-169.
29. You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000 Oct 4; 92(Suppl 19): 1607-1612.
30. Sasazuki S, Sasaki S, Tsubono Y, et al. The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection. Cancer Sci 2003 Apr; 94(Suppl 4): 378-382.
31. Correa P, Fontham ET, Bravo JC, et al. Chemoprevention of gastric dysplasia: Randomized trial of antioxidant supplements and anti-Helicobacter pylori therapy. J Natl Cancer Inst 2000 Dec 6; 92(Suppl 23): 1881-1888.
32. Correa P, Malcom. G, Schmidt B, et al. Review article: Antioxidant micronutrients and gastric cancer. Aliment Pharmacol Ther 1998; 12(Suppl 1): 73-82.
33. Meyer B, Werth B, Beglinger C, et al. Helicobacter pylori infection in healthy people: A dynamic process? Gut 1991; 32: 347.